 2007 (a total of 1033 patients treated),

with a signiﬁcant decrease in mortality from 45% in
open repair to 24% with TEVAR (P < .001).202 It is likely
that there is an early survival advantage to treating
ruptured DTA with TEVAR over open repair.
There appear to be advantages to TEVAR over open
repair of the DTA beyond survival. A meta